A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma için istatistikler

Toplam ziyaret

views
A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma 0

Aylık toplam ziyaret

views
Aralık 2024 0
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0
Mayıs 2025 0
Haziran 2025 0

Dosya Ziyaretleri

views
Artificial-intelligence-in-reproductive-endocrinology-an-indepth-longitudinal-analysis-of-ChatGPTv4s-monthbymonth-interpretation-and-adherence-to-clinical-guidelines-for-diminished-ovarian-reserveEndocrine.pdf 12